References
- Hadshiew, I.M., Foitzik, K., Arck, P.C., R. Paus, R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol 123: 455-457, 2004. https://doi.org/10.1111/j.0022-202X.2004.23237.x
- Kaufman, K.D. Androgens and alopecia. Mol Cell Endocrinol 198: 89-95, 2002. https://doi.org/10.1016/S0303-7207(02)00372-6
- Soni, V.K. Androgenic alopecia: a counterproductive outcome of the anabolic effect of androgens. Med Hypotheses 73: 420-426, 2009. https://doi.org/10.1016/j.mehy.2009.03.032
- Ahmad, W., Faiyaz ul Haque, M., Brancolini, V., Tsou, H.C., ul Haque, S., Lam, H., Aita, V.M., Owen, J., deBlaquiere, M., Frank, J., Cserhalmi-Friedman, P.B., Leask, A., McGrath, J.A., Peacocke, M., Ahmad, M., Ott, J., Christiano, A.M. Alopecia universalis associated with a mutation in the human hairless gene. Science 279: 720-724, 1998. https://doi.org/10.1126/science.279.5351.720
- Ellis, J.A., Stebbing, M., Harrap, S.B. Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 116: 452-455, 2001. https://doi.org/10.1046/j.1523-1747.2001.01261.x
- Peters, E.M., Liotiri, S., Bodo, E., Hagen, E., Biro, T., Arck, P.C., Paus, R. Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol 171: 1872-1886, 2007. https://doi.org/10.2353/ajpath.2007.061206
- Gilhar, A., Keren, A., Shemer, A., d'Ovidio, R., Ullmann, Y., Paus, R. Autoimmune Disease Induction in a Healthy Human Organ: A Humanized Mouse Model of Alopecia Areata. J Invest Dermatol 133: 844-847, 2013. https://doi.org/10.1038/jid.2012.365
- Price, V.H. Treatment of hair loss. New Engl J Med 341: 964-973, 1999. https://doi.org/10.1056/NEJM199909233411307
- Kaufman, K.D., Olsen, E.A., Whiting, D., Savin, R., DeVillez, R., Bergfeld, W., Price, V.H., Van Neste, D., Roberts, J.L., Hordinsky, M., Shapiro, J., Binkowitz, B., Gormley, G.J. and Finasteride Male Pattern Hair Loss Study G. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 39: 578-589, 1998. https://doi.org/10.1016/S0190-9622(98)70007-6
- Georgala, S., Befon, A., Maniatopoulou E., and Georgala, C. Topical use of minoxidil in children and systemic side effects. Dermatology 214: 101-102, 2007. https://doi.org/10.1159/000096924
- Rogers, N.E. and Avram, M.R. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol 59: 547-566, 2008. https://doi.org/10.1016/j.jaad.2008.07.001
- Irwig, M.S. Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects. J. Clin. Psychiat. 73: 1220-1223, 2012. https://doi.org/10.4088/JCP.12m07887
- Irwig, M.S. Persistent sexual side effects of finasteride: could they be permanent? J Sex Med 9: 2927-2932, 2012. https://doi.org/10.1111/j.1743-6109.2012.02846.x
- Prausnitz, M.R. Microneedles for transdermal drug delivery. Adv Drug Delivery Rev 56: 581-587, 2004. https://doi.org/10.1016/j.addr.2003.10.023
- Kulkarni, V.S. Microneedle-minimally invasive transdermal delivery technology, in: Kaushik D, Kilfoyle B, Thakur R, Michniak-Kohn BB(Eds.), Handbook of Non-Invasive Drug Delivery Systems. Elservier Inc., MA, USA, 135-164, 2010.
- Kuhn, H.G. and Cooper-Kuhn, C.M. Bromodeoxyuridine and the detection of neurogenesis. Curr. Pharm. Biotechno. 8: 127-131, 2007. https://doi.org/10.2174/138920107780906531
- Stenn, K.S. and Paus, R. Controls of hair follicle cycling. Physiol Rev 81: 449-494, 2001.
- Krause, K. and Foitzik K. Biology of the hair follicle: the basics. Semin Cutan Med Surg 25: 2-10, 2006. https://doi.org/10.1016/j.sder.2006.01.002
- Paus, R. and Cotsarelis, G. The biology of hair follicles. New Engl J Med 341: 491-497, 1999. https://doi.org/10.1056/NEJM199908123410706
- Crabtree, J.S., Kilbourne, E.J., Peano, B.J., Chippari, S., Kenney, T., McNally, C., Wang, W., Harris, H.A., Winneke,r R.C., Nagpal, S. and Thompson, C.C. A Mouse Model of Androgenetic Alopecia. Endocrinology 151: 2373-2380, 2010. https://doi.org/10.1210/en.2009-1474
- Kwack, M.H., Kang B.M., Kim M.K., Kim J.C. and Sung Y.K. Minoxidil activates beta-catenin pathway in human dermal papilla cells: a possible explanation for its anagen prolongation effect. J Dermatol Sci 62: 154-159, 2011. https://doi.org/10.1016/j.jdermsci.2011.01.013
- Wilson, C., Walkden, V., Powell, S., Shaw, S., Wilkinson, J. and Dawber, R. Contact dermatitis in reaction to 2% topical minoxidil solution. J Am Acad Dermatol 24: 661-662, 1991. https://doi.org/10.1016/S0190-9622(08)80171-5
- Werner, S., Grose, R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 83: 835-870, 2003.
- Gurtner, G.C., Werner, S., Barrandon, Y., Longaker, M.T. Wound repair and regeneration. Nature 453: 314-321, 2008. https://doi.org/10.1038/nature07039
- Ota, Y., Saitoh, Y., Suzuki, S., Ozawa, K., Kawano, M., Imamura, T. Fibroblast growth factor 5 inhibits hair growth by blocking dermal papilla cell activation. Biochem Biophys Res Commun 290: 169-176, 2002. https://doi.org/10.1006/bbrc.2001.6140
- Yano, K., Brown, L.F., Detmar, M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 107: 409-417, 2001. https://doi.org/10.1172/JCI11317
- Li, W., Lu, Z.F., Man, X.Y., Li, C.M., Zhou, J., Chen, J.Q., Yang, X.H., Wu, X.J., Cai, S.Q., Zheng, M. VEGF upregulates VEGF receptor-2 on human outer root sheath cells and stimulates proliferation through ERK pathway. Mol Biol Rep 39: 8687-8694, 2012. https://doi.org/10.1007/s11033-012-1725-6
- Li, W., Man, X.Y., Li, C.M., Chen, J.Q., Zhou, J., Cai, S.Q., Lu, Z.F., Zheng, M. VEGF induces proliferation of human hair follicle dermal papilla cells through VEGFR-2-mediated activation of ERK. Exp Cell Res 318: 1633-1640, 2012. https://doi.org/10.1016/j.yexcr.2012.05.003